, Singapore
5 views

Singapore to revamp public health subsidy system

The basis for hospital subsidies will be changed to per capita household income.

Singapore is revising its public healthcare subsidy framework to benefit those with greater needs, amidst a rising consumption of healthcare services as the population ages.

To ensure that people at the lowest income levels get the help that they need to improve their health outcomes, the Ministry of Health (MOH) will channel more money to them, which would entail a major revamp of the public sector subsidy structure by the middle of 2022 that will affect inpatient and outpatient subsidies, according to Fitch Solutions.

There will be changes to the subsidies in acute and community hospitals, specialist outpatient clinics and for day surgery. There will also be just one subsidy range for the two subsidised ward classes - B2 and C - that will go from 50% to 80%.

“The change will mean higher subsidies for lower income patients who opt for B2 class, and lower subsidies for higher income patients in C class. The lowest quintile already gets the lion's share of subsidies, 37% in 2018,” the report stated.

Changes to the subsidy system will further tilt the financial help in their favour, Fitch noted. Hospital subsidies will change from being based on an individual's income to per capita household income to reflect the number of people dependent on that person's income.

MOH is also planning to address health needs across a person's life. To help the young ‘start well and achieve their fullest potential’, the ministry will develop a child and maternal health and well-being strategy that will span pre-conception to 18 years of age.

At the other end of the spectrum, $143m (S$180m) has been set aside to roll out more than 200 eldercare centres that will have active ageing programmes, befriending and care services.

The report noted that an ageing population, a preference for innovative medicines, and the population's access to new and advanced healthcare technologies will result in the continued growth of Singapore’s healthcare market.

According to the health minister, Singapore's healthcare expenditure is set to continue to rise, largely due to the development of new facilities and the cost of running them.

Singaporeans are also utilising more healthcare than in the past which is partly the result of making care more accessible and affordable to all, and partly due to earlier diagnosis and closer monitoring and follow-ups for medical conditions, Fitch added.
 

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox

Find out who won at this year's Healthcare Asia Awards and Healthcare Asia Pharma Awards 

The event was held via video conferencing that started last 15 April.

What investment opportunities await for India’s health-tech space?

Before the pandemic, the industry focussed on wearables, lifestyle-linked problems, and more.

Singapore’s Tan Tock Seng Hospital closes wards to visitors

Two patients and two staff were infected by COVID-19.

Hygeia Healthcare buys 100% stake in Etern Group for $268m

The acquisition indirectly holds 98% of Suzhou Yongding Hospital in Jiangsu.

How reach52 bridges the gap in healthcare with tech

The unique startup aims to connect to 250 million individuals across the globe by 2030.

He Health bags internet hospital license in China

The online platform offers services such as men’s health consultations.

Indonesia's telehealth platform Halodoc bags $80m in funding

The funds will be used to deepen its penetration in key healthcare verticals in Indonesia.

South Korea eases requirements for drug imports

Pharmaceutical companies could benefit from the government’s drive to reduce regulatory uncertainty.

Taiwan's novel pharma products hit by low reimbursement prices

The low rates are discouraging the launch of new innovative products, insiders say.

Japan's liver cancer surveillance program hailed as world's best

The country established the programme for early detection of HCC in the 1980s.